Lv5
1070 积分 2022-05-20 加入
Induced proximity-based therapeutic modalities
21天前
已完结
Disrupted molecular glue complex drives RAS inhibitor resistance
1个月前
已完结
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
1个月前
已完结
Clinical pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation
5个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
8个月前
已完结
皖公网安备34019202002308
